Avandia users were 1.2 times as likely to have a heart attack as patients given sulfonylurea. Avandia (rosiglitazone) is manufactured by GlaxoSmithKline PLC ...
... that compared the effects of rosiglitazone (Avandia, GlaxoSmithKline), glyburide and metformin on glycemic control in patients with type 2 diabetes. ...
... safety data issued in the wake of controversy over the diabetes drug rosiglitazone (Avandia), which was shown to increase cardiovascular event risks. ...
For example, Avandia ( rosiglitazone ) was found to increase the probability of heart risks and other heart related problems in type-2 diabetes patients. ...
Another study with a composite endpoint was a 2006 study of rosiglitazone (Avandia) called DREAM. Its primary endpoint combined death with incidence of ...
